表皮蛋白质组学显示Elafin是银屑病特异性生物标志物并揭示银屑病斑块周围抗炎活性增加
本研究采用无创表皮取样对病变、病变周围及非病变皮肤进行蛋白质组学分析,比较银屑病与湿疹。ELISA和ROC曲线分析53例银屑病和42例湿疹样本显示,Elafin的敏感性和特异性优于IL-36γ。IL-37在银屑病病变周围皮肤上调,可能参与斑块边界清晰。
要点
- Elafin在区分银屑病与湿疹方面敏感性和特异性优于IL-36γ。
- IL-37在银屑病病变周围皮肤上调,非病变皮肤也见固有差异。
- 无创表皮蛋白质组学有助理解银屑病与湿疹的分子差异。
核心结论
- Elafin是区分银屑病与湿疹的稳健特异性生物标志物,IL-37在银屑病病变周围皮肤上调。
研究设计与样本
- 对病变、病变周围及非病变皮肤进行无创表皮取样,行蛋白质组学分析,并用ELISA和ROC曲线分析53例银屑病和42例湿疹样本。
主要发现
- IL-36γ是银屑病病变的优良蛋白质生物标志物。
- Elafin在区分银屑病与湿疹的敏感性和特异性上优于IL-36γ。
- Elafin在非病变银屑病皮肤的非好发部位也上调。
- IL-37在银屑病病变周围皮肤上调,但病变皮肤未上调。
- IL-37高表达见于银屑病而非特应性皮炎或自身免疫性大疱病病变周围皮肤。
临床怎么用
- Elafin和IL-36γ可作为区分银屑病与湿疹的候选生物标志物。
- 无创表皮取样蛋白质组学可用于探索皮肤病的诊断和病理生理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Eczema and psoriasis are common diseases. Despite both showing active epidermal contribution to the inflammatory process, their molecular aetiology and pathological mechanisms are different. OBJECTIVE: Further molecular insight into these differences is therefore needed to enable effective future diagnostic and treatment strategies. The majority of our mechanistic and clinical understanding of psoriasis and eczema is derived from RNA, immunohistology and whole skin biopsy data. METHODS: In this study, non-invasive epidermal sampling of lesional, perilesional and non-lesional skin from diseased and healthy skin was used to perform an in depth proteomic analysis of epidermal proteins. RESULTS: Our findings confirmed the psoriasis-associated cytokine IL-36γ as an excellent protein biomarker for lesional psoriasis. However, ELISA and ROC curve analysis of 53 psoriasis and 42 eczema derived samples showed that the sensitivity and specificity were outperformed by elastase-specific protease inhibitor, elafin. Of note, elafin was also found upregulated in non-lesional psoriatic skin at non-predilection sites demonstrating inherent differences between the non-involved skin of healthy and psoriatic individuals. Mass spectrometry and ELISA analysis also demonstrated the upregulation of the anti-inflammatory molecule IL-37 in psoriatic perilesional but not lesional skin. The high expression of IL-37 surrounding psoriatic plaque may contribute to the sharp demarcation of inflammatory morphology changes observed in psoriasis. This finding was also specific for psoriasis and not seen in atopic dermatitis or autoimmune blistering perilesional skin. Our results confirm IL-36γ and add elafin as robust, hallmark molecules distinguishing psoriasis and eczema-associated inflammation even in patients under systemic treatment. CONCLUSIONS: Overall, these findings highlight the potential of epidermal non-invasive sampling and proteomic analysis to increase our diagnostic and pathophysiologic understanding of skin diseases. Moreover, the identification of molecular differences in healthy-looking skin between patients and healthy controls highlights potential disease susceptibility markers and proteins involved in the initial stages of disease.
引用
- Berekmeri A, Macleod T, Hyde I, et al. Epidermal proteomics demonstrates Elafin as a psoriasis-specific biomarker and highlights increased anti-inflammatory activity around psoriatic plaques. J Eur Acad Dermatol Venereol. 2024. PMID: 39157924. doi:10.1111/jdv.20289
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。